Abstract
The influence of bopindolol monotherapy on blood pressure and plasma lipid fractions was investigated in 24 hypertensive patients. Bopindolol lowered blood pressure and heart rate significantly. When compared with placebo no changes were found in the plasma concentrations of total cholesterol, LDL cholesterol and HDL cholesterol. Plasma triglycerides were significantly increased after 4 and 8 weeks but not after 12 weeks of bopindolol. It is concluded that bopindolol is an effective and well tolerated beta-adrenoceptor blocker in hypertensive patients. The fact that it does not lower HDL cholesterol could be a potential advantage.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berglund G., Andersson O. beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects. Lancet. 1981 Apr 4;1(8223):744–747. doi: 10.1016/s0140-6736(81)92624-6. [DOI] [PubMed] [Google Scholar]
- Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970 Nov;11(6):583–595. [PubMed] [Google Scholar]
- Hulthén U. L., van Brummelen P., Amann F. W., Bühler F. R. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age. J Cardiovasc Pharmacol. 1983 May-Jun;5(3):426–429. doi: 10.1097/00005344-198305000-00012. [DOI] [PubMed] [Google Scholar]
- Johnson B. F. The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol. 1982;4 (Suppl 2):S213–S221. [PubMed] [Google Scholar]
- Leren P., Foss P. O., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet. 1980 Jul 5;2(8184):4–6. doi: 10.1016/s0140-6736(80)92888-3. [DOI] [PubMed] [Google Scholar]
- van Brummelen P., Bühler F. R., Amann F. W., Bolli P. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. Eur J Clin Pharmacol. 1982;22(6):491–493. doi: 10.1007/BF00609620. [DOI] [PubMed] [Google Scholar]
- van Brummelen P. The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids. J Cardiovasc Pharmacol. 1983;5 (Suppl 1):S51–S55. doi: 10.1097/00005344-198300051-00008. [DOI] [PubMed] [Google Scholar]